Bliss GVS Pharma Share Price

    NSE
    154.01
    +0.22 (0.65%)
    BLISSGVS • 11 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    32.03%

    3Y Annualised Return

    26.74%

    5Y Annualised Return

    7.63%

    The current prices are delayed, login or Open Demat Account for live prices.

    Bliss GVS Pharma Stock Performance

    1W Return-1.56
    1Y Return32.06
    Today's Low153.48
    Prev. Close153.79
    Mkt Cap (Cr.)1,621.96
    1M Return0.73
    3Y Return108.01
    52-Week High185.5
    Open154.47
    PE Ratio23.51
    6M Return-4.14
    Today's High158.5
    52-Week Low106.04
    Face Value1

    Bliss GVS Pharma Company background

    Founded in: 1984
    Managing director: Gagan Harsh Sharmma
    Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries fastestgrowing businesses. The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries. It has a strong foothold in Sub Saharan Africa. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its own manufacturing facility at Palghar which is WHO GMP approved. The business operates five cuttingedge production facilities that adhere to WHOGMP, EUMP, ISO 14001 and OHSAS 45001 standards.The company has a dedicated the RD Centre for development of Suppositories, Semi Solids and Oral Solids with an experienced Team of over 50 Scientists for formulation development and analytical method development and certified by the Department of Scientific Industrial Research (DSIR), Government of India.The company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharmas RD center, received approval from Government of Indias Department for Scientific Industrial Research (DSIR).During the year under review, the company invested in 51% share capital of Lifeon Labs Pvt Ltd. During the year under review, Bliss GVS Pharma faced challenges in Ghana, where delays in registration resulted in adverse regulatory action. However, the company took quick, corrective measures to resolve these issues. The business is now backing on track in Ghana.During the year ended 31 March 2015, Bliss GVS Pharma formed a new company Asterisk Lifesciences Limited as a wholly owned foreign subsidiary in United Kingdom for the purpose of facilitating registrations and marketing of pharmaceutical formulations in the European continent.During the financial year ended 31 March 2016, Bliss GVS Pharma continued to grow in various geographies in Kenya, Nigeria and France. Such growth was mainly achieved due to contract manufacturing and consistent focus on new product launch in Kenya and Nigeria. Bliss GVS Pharma continued to strengthen its operations and creation of robust Quality Manufacturing operations during the year ended 31 March 2017,The companys investment in managed healthcare services delivered encouraging results with the company procuring USD 111.40 mMillion contract from Aon. During the year ended 31 March 2018, Bliss GVS Pharma divested three subsidiaries viz. Lifeon Labs Private Limited, Bliss Indasi Lifescience Private Limited and Shree Salespack Private Limited and one materially significant step down subsidiary Bliss GVS Healthcare Limited, Nairobi to focus on its core pharmaceutical operations, which have been a steady source of growth.The Company set up a multidosage facility at Vevoor, Maharashtra in 2019. The first phase commissioned earlier in March, 2020, primarily for Tablets, Capsules, Dry Syrups, and Sachets. While the second phase commenced construction in January, 2021.

    As of 11 Jul, 2025, Bliss GVS Pharma share price is ₹153.8. The stock opened at ₹154.5 and had closed at ₹153.8 the previous day. During today’s trading session, Bliss GVS Pharma share price moved between ₹153.48 and ₹158.50, with an average price for the day of ₹155.99. Over the last 52 weeks, the stock has recorded a low of ₹106.04 and a high of ₹185.50. In terms of performance, Bliss GVS Pharma share price has declined by 4.1% over the past six months and has increased by 32.03% over the last year.

    Read More
    Bliss GVS Pharma SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹76,65,539 (+17.93%)
    Daily SIP of 25,000 would have become 76,65,539 in 1 year with a gain of 11,65,539 (+17.93%)
    View details of Market Depth

    Bliss GVS Pharma Fundamental

    Market Cap (in crs)

    1,621.96

    Face Value

    1

    Turnover (in lacs)

    572.18

    Key Metrics

    Qtr Change %
    45.06% Gain from 52W Low
    32.1
    Dividend yield 1yr %
    Below industry Median
    0.3

    Bliss GVS Pharma Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Bliss GVS Pharma Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    197.99 Cr
    210.42 Cr
    217.68 Cr
    183.64 Cr
    198.13 Cr
    Bliss GVS Pharma Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    846.22 Cr
    798.98 Cr
    769.37 Cr
    778.95 Cr
    597.43 Cr
    728.49 Cr
    Bliss GVS Pharma Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    16.65 Cr
    25.8 Cr
    25.69 Cr
    22.11 Cr
    -4.91 Cr
    Bliss GVS Pharma Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    90.26 Cr
    81.58 Cr
    76.73 Cr
    23.13 Cr
    73.97 Cr
    95.25 Cr

    Bliss GVS Pharma Result Highlights

    • Bliss GVS Pharma Ltd reported a 9.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 8.5%.

    • Its expenses for the quarter were down by 5.7% QoQ and 5.3% YoY.

    • The net profit decreased 119.1% QoQ and decreased 242.2% YoY.

    • The earnings per share (EPS) of Bliss GVS Pharma Ltd declined at 0.9 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Bliss GVS Pharma

    Promoter
    35.3%
    Foreign Institutions
    13.2%
    Domestic Institutions
    6.5%
    Public
    45%
    Promoter
    35.1%
    Foreign Institutions
    13.5%
    Domestic Institutions
    6.6%
    Public
    44.8%
    Promoter
    34.8%
    Foreign Institutions
    12.1%
    Domestic Institutions
    6.6%
    Public
    46.5%
    Promoter
    34.9%
    Foreign Institutions
    13.2%
    Domestic Institutions
    6.6%
    Public
    45.3%
    Promoter
    35%
    Foreign Institutions
    14.7%
    Domestic Institutions
    6.6%
    Public
    43.7%
    Promoter
    35%
    Foreign Institutions
    15.4%
    Domestic Institutions
    6.6%
    Public
    43.1%

    Bliss GVS Pharma Technical Analysis

    Moving Averages Analysis
    154.01
    Current Price
    Bullish Moving Averages
    11
    Bearish Moving Averages
    5
    5Day EMA
    155.60
    10Day EMA
    155.20
    12Day EMA
    154.60
    20Day EMA
    151.50
    26Day EMA
    149.20
    50Day EMA
    142.40
    100Day EMA
    137.80
    200Day EMA
    134.30
    5Day SMA
    157.50
    10Day SMA
    156.80
    20Day SMA
    151.20
    30Day SMA
    147.40
    50Day SMA
    137.30
    100Day SMA
    130.50
    150Day SMA
    140.50
    200Day SMA
    138.20
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    156304 Rs
    394330 Rs
    Week Rs
    244873 Rs
    630263 Rs
    Month Rs
    231785 Rs
    730693 Rs
    155.27
    Pivot
    Resistance
    First Resistance
    157.05
    Second Resistance
    160.29
    Third Resistance
    162.07
    Support
    First Support
    152.03
    Second support
    150.25
    Third Support
    147.01
    Relative Strength Index
    57.08
    Money Flow Index
    76.80
    MACD
    5.41
    MACD Signal
    6.10
    Average True Range
    6.58
    Average Directional Index
    36.51
    Rate of Change (21)
    3.63
    Rate of Change (125)
    -7.86
    Name
    Holding Percent
    Arian Investment Limited
    8.58
    Coeus Global Opportunities Fund
    1.76
    Life Insurance Corporation Of India
    6.55

    Bliss GVS Pharma Latest News

    10 JUL 2025 | Thursday

    Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    09 JUL 2025 | Wednesday

    Bliss GVS Pharma Ltd - 506197 - Business Responsibility and Sustainability Reporting (BRSR)

    09 JUL 2025 | Wednesday

    Bliss GVS Pharma Ltd - 506197 - Notice Of The 40Th Annual General Meeting ('40Th AGM') Of Bliss GVS Pharma Limited

    View More

    Bliss GVS Pharma Share Price FAQs

    Bliss GVS Pharma share price is ₹154.01 in NSE and ₹154 in BSE as on 11/7/2025.

    Bliss GVS Pharma share price in the past 1-year return was 32.05. The Bliss GVS Pharma share hit a 1-year low of Rs. 106.04 and a 1-year high of Rs. 185.5.

    The market cap of Bliss GVS Pharma is Rs. 1621.96 Cr. as of 11/7/2025.

    The PE ratios of Bliss GVS Pharma is 23.51 as of 11/7/2025.

    The PB ratios of Bliss GVS Pharma is 1.53 as of 11/7/2025

    You can easily buy Bliss GVS Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Bliss GVS Pharma share price is ₹185.5 and ₹106.04 as of 11/7/2025.

    Please be aware that Bliss GVS Pharma stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.92
    -0.05 (-0.08%)
    135.28
    -1.85 (-1.35%)
    681.80
    -13.80 (-1.98%)
    2,558.70
    -22.30 (-0.86%)
    160.00
    -9.64 (-5.68%)
    381.65
    -3.05 (-0.79%)
    159.84
    -0.82 (-0.51%)
    263.35
    +0.50 (+0.19%)
    409.30
    -4.20 (-1.02%)
    396.85
    -3.05 (-0.76%)
    Top Gainers
    2,519.60
    +111.20 (+4.62%)
    1,835.20
    +25.00 (+1.38%)
    1,173.80
    +9.50 (+0.82%)
    2,220.60
    +16.80 (+0.76%)
    858.85
    +6.00 (+0.70%)
    Top Losers
    3,266.00
    -116.00 (-3.43%)
    3,073.20
    -89.20 (-2.82%)
    8,067.00
    -218.00 (-2.63%)
    258.30
    -6.75 (-2.55%)
    4,218.70
    -102.60 (-2.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -